CYTK
CYTK's valuation appears fair, below average fundamentals limit its appeal, while forward estimates point to narrowing losses and improving margins, though estimates vary widely.
CYTK vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| EPS | -$7.22 | -$4.35 | $2.87 lower-$2.87 |
| FCF | -$580.7M | -$318.6M | -$262.1M-$262.1M |
| Loading historical comparisons… | |||
CYTK’s earnings are below their historical averages.
CYTK Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Loss narrowing |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Wide |
CYTK’s outlook is generally improving, though analysts differ widely on the estimates.
CYTK PE Valuation
This table applies CYTK's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
CYTK Earnings Per Share
This chart tracks CYTK's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
CYTK Quarterly Revenue
This chart tracks CYTK's quarterly revenue over time and shows how sales are changing from year to year.
CYTK Free Cash Flow
This chart tracks CYTK's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
CYTK Total Shares
This chart tracks changes in CYTK's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
CYTK Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
CYTK PE vs Healthcare Sector
This chart compares CYTK's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
CYTK Weekly Price
This chart uses CYTK's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
CYTK Weekly Moving Averages
This chart compares CYTK's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
CYTK Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
OSCR
OSCR's valuation appears fair, fundamentals are above averages and forward estimates point to earnings and revenue growth, though analyst coverage is limited and estimates vary widely.
OSCR vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 23x | 126x | 81% lower-81% |
| PE percentile | 7.1 | 51 | 86% lower-86% |
| EPS | $1.40 | -$2.08 | $3.48 higher+$3.48 |
| FCF | $4.3B | $451.9M | 859% higher+859% |
| Loading historical comparisons… | |||
OSCR’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Strong growth |
| Forward profitability | Stable |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
OSCR’s outlook is generally improving, though analyst coverage is limited.
OSCR PE Valuation
This table applies OSCR's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
OSCR Earnings Per Share
This chart tracks OSCR's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
OSCR Quarterly Revenue
This chart tracks OSCR's quarterly revenue over time and shows how sales are changing from year to year.
OSCR Free Cash Flow
This chart tracks OSCR's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
OSCR Total Shares
This chart tracks changes in OSCR's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
OSCR Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
OSCR PE vs Healthcare Sector
This chart compares OSCR's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
OSCR Weekly Price
This chart uses OSCR's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
OSCR Weekly Moving Averages
This chart compares OSCR's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
OSCR Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.